Jenn Adams named Healthcare Technology CEO of the Year
04.01.26
Features

At this year’s NYC Awards Night, we had the privilege of recognizing several exceptional leaders advancing innovation across healthcare technology.

Congratulations to Jenn Adams, CEO of August Bioservices, on being named Healthcare Technology CEO of the Year.

Jenn has led August Bioservices since its founding in 2020, building a contract development and manufacturing organization (CDMO) dedicated to sterile injectable therapies. Headquartered in Nashville, the company provides development and manufacturing services that help drug developers advance innovative therapies from early development through commercialization.

Accepting the award, Jenn shared: “When we started our company five and a half years ago, we had a really clear goal and we set out to build a CDMO focused on sterile injectables that could truly serve as a partner to our clients, providing deep technical expertise and a state-of-the-art facility and equipment — all designed to help advance innovative therapies through development and commercialization. Our aspiration is to show up so fully for our clients that they cannot tell the difference anymore. It’s indistinguishable to them who is on their team and who is on our team because we’re working shoulder to shoulder to make sure the drug is advanced. And then we’re bridging the innovation and bringing it to patients who need that innovation in the form of therapies.”

Please join us in congratulating Jenn Adams on this well-deserved recognition.

The next GrowthCap Forum event will take place this summer in Jackson Hole, WY. Learn more here.

 Picture: Jenn Adams speaks at NYC Awards Night

NYCAN 2026. NYCAN Video Clip

Growth Investor Weekly

Discover unique insights from growth investors and leading executives.

Sign up for our weekly newsletter.

Top Go Back
© GrowthCap, LLC. All rights reserved.

Sign up for GrowthCap Insights